
Sign up to save your podcasts
Or


Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 15 minutes long and presents 5-6 recently published articles from ADA journals.
Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.
This month we review articles on: 1. Glargine U-300 vs Glargine U-100 2. Accuracy of Blood Glucose Monitors 3. Time to Start and Intensify Medications 4. Hypoglycemia and Death in the LEADER Trial 5. Empagliflozin and Fracture Risk 6. Empagliflozin and Non-alcoholic Fatty Liver
For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.
Presented by:
Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine; Associate Director, Family Medicine Residency Program, Abington Memorial Hospital.
John J. Russell, M.D., Associate Professor of Family and Community Medicine, Temple University School of Medicine; Director, Family Medicine Residency Program, Abington Memorial Hospital.
By American Diabetes Association4.5
9696 ratings
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 15 minutes long and presents 5-6 recently published articles from ADA journals.
Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.
This month we review articles on: 1. Glargine U-300 vs Glargine U-100 2. Accuracy of Blood Glucose Monitors 3. Time to Start and Intensify Medications 4. Hypoglycemia and Death in the LEADER Trial 5. Empagliflozin and Fracture Risk 6. Empagliflozin and Non-alcoholic Fatty Liver
For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.
Presented by:
Neil S. Skolnik, M.D., Professor of Family and Community Medicine, Temple University School of Medicine; Associate Director, Family Medicine Residency Program, Abington Memorial Hospital.
John J. Russell, M.D., Associate Professor of Family and Community Medicine, Temple University School of Medicine; Director, Family Medicine Residency Program, Abington Memorial Hospital.

320 Listeners

696 Listeners

500 Listeners

1,724 Listeners

870 Listeners

886 Listeners

3,362 Listeners

1,142 Listeners

44 Listeners

516 Listeners

368 Listeners

37 Listeners

424 Listeners

11 Listeners

22 Listeners